<DOC>
	<DOCNO>NCT00714129</DOCNO>
	<brief_summary>The worldwide epidemic obesity parallel increased case non-alcoholic liver disease ( liver fat accumulation ) diabetes . Fat belongs adipose tissue , excess fat accumulates liver muscle , tissue use sugar efficiently . It discover large quantity fructose ( sugar present soft drink ) consume , conversion carbohydrate ( CHO ) fat liver increase . We hypothesize : 1 ) subject fatty liver high CHO uptake conversion fat liver compare match control subject normal liver fat content ; : 2 ) subject fatty liver feed diet limit fructose simple sugar decrease liver CHO fat content . This reduction liver fat normalize way liver responds sugar insulin , reverse pre-diabetic state . The measurement parameter do use state-of-the-art technique safe non-radioactive isotope tracer non-invasive magnetic resonance spectroscopy . For information , please call 415-206-5532 phone screening</brief_summary>
	<brief_title>De Novo Lipogenesis , Lipid Carbohydrate Metabolism Non-alcoholic Fatty Liver Disease</brief_title>
	<detailed_description>Non-alcoholic fatty liver disease ( NAFLD ) common liver ailment develop country . Fatty liver - steatosis - affect one third population . Its prevalence rise seem parallel global increase obesity type-2 diabetes . The etiology NAFLD human well understood . We propose hepatic conversion carbohydrate ( CHO ) lipid ( de novo lipogenesis , DNL ) key factor accumulation excess liver fat accompany dyslipidemia hepatic insulin resistance ; suppress DNL diet reduce liver fat improve lipid carbohydrate metabolism patient steatosis . These hypothesis base study others establish fractional hepatic DNL vary dramatically depend diet and/or health status subject ; , particular , dietary fructose potent lipogenic stimulus . In proposal perform CRC-based study compare rate DNL low density lipoprotein ( VLDL ) kinetics steatotic match non-steatotic control evaluate relationship lipid profile hepatic whole-body insulin resistance overall carbohydrate metabolism ( Aim1 ) . The steatotic individual whose habitual intake fructose simple sugar exceed 15 % total energy intake randomized consume one two low-fat diet differ CHO type determine whether diet-induced change DNL affect liver fat flux content hepatic , whole-body insulin sensitivity , overall carbohydrate metabolism ( Aim 2 ) . We hypothesize diet rich complex CHO achieve great decrease DNL liver fat one contain typical amount simple CHO , include fructose . This dietary intervention study include 6-week 25 % energy restriction outpatient phase promote moderate weight loss improve insulin sensitivity , follow two week weight maintenance last 4 day inpatient stay study perform baseline ( Aim 1 ) repeat . State-of-the-art stable isotope technique use assess hepatic DNL , apoB100 turnover , VLDL-triglyceride ( TG ) flux , lipolysis fast feed condition . Hepatic extra-hepatic insulin sensitivity measure use hyperinsulinemic-euglycemic clamp stable isotope study endogenous glucose production glycogen flux . Liver muscle fat measure proton magnetic resonance spectroscopy ( MRS ) , visceral fat magnetic resonance imaging ( MRI ) , whole-body composition dual-energy X-ray absorptiometry ( DEXA ) . These study allow u evaluate importance DNL mechanism modulate liver fat content flux , significance CHO quality dietary guidance steatotic patient .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>In steatotic subject , steatosis diagnose MRS liver biopsy &gt; 33 % hepatocytes contain fat . Nonsteatotic control biopsy since medically warrant ; thus , ensure steatosis undergo MRS screen total lipid : unsuppressed water &lt; 0.05 . Habitual consumption alcohol &gt; 20 g/day men 10 g/day woman Confirmed HIV1 infection , Hgb &lt; 13 g/dL male &lt; 12 g/dL female Abnormal hepatitis B C serology Diabetes current use antidiabetic hypolipidemic agent Presence metalcontaining substance body ( e.g . fragment eye , aneurysm clip , ear implant , spinal nerve stimulators pacemaker ) Weight 350 pound severe claustrophobia , would preclude MR study Any condition would preclude adherence protocol ability provide inform consent Change body weight &gt; 5 % within precede 6 month ( selfreport ) Known intolerance , allergy hypersensitivity fructose Pregnancy lactation ( woman ) ; OR Any condition , opinion investigator , would put subject risk .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Steatosis</keyword>
	<keyword>Diabetes</keyword>
</DOC>